Search

Aim: Clinical staging of schizophrenia entails a new method that identifies clusters of symptoms and variation in level of remission, with the goal to create a framework for early intervention. Additionally, duration of untreated psychosis (DUP) may influence symptom severity in the first episode of psychosis (FEP) and could necessitate refining of the staging model. However, consistent evidence concerning variation in symptom severity and DUP between stages is missing. Therefore, we evaluated the clinical validity of the staging model by investigating differences in symptom severity across stages in schizophrenia spectrum disorders. Second, we assessed if a prolonged DUP is associated with higher symptom severity in FEP. Methods: We performed a cross‐sectional study of 291 acutely admitted patients with a schizophrenia spectrum disorder. Patients were assigned to clinical stages following the definition of McGorry. Symptom severity was evaluated with the new DSM‐5 Clinician‐Rated Dimensions of Psychosis Symptom Severity (CRDPSS). In FEP, we determined the DUP. Results: Significantly higher severity scores of CRDPSS items hallucinations (H = 14.34, df = 4, P‐value =.006), negative symptoms (H = 19.678, df = 4, P‐value =.001) and impaired cognition (H = 26.294, df = 4, P‐value = <.001) were found in more advanced stages of disease. Moreover, patients with FEP and a DUP longer than 1 year showed significantly more severe negative symptoms (U = 314 000, P =.015) compared to patients with a DUP shorter than 1 year. Conclusions: The present study found supporting evidence for the clinical validity of the staging model in schizophrenia spectrum disorders. In addition, we found support for refining the stage "first episode" with information concerning the DUP. [ABSTRACT FROM AUTHOR]

Objectives: Profile characteristics are factors that are relevant for diagnosis, prognosis or treatment. The present study aims to develop a set of clinically relevant profile characteristics. Moreover, our goal is to determine the inter‐rater reliability (IRR) of the selected profile characteristics. Methods: Potential profile characteristics were determined by literature review. Assessment of IRR was done by comparing scores on profile characteristics determined by two researchers. We conducted three subsequent studies: (1) assessment of pre‐training IRR, (2) IRR following implementation of an instruction manual, (3) IRR after optimizing scoring methods. IRR was measured with the Intraclass Correlation Coefficient (ICC). Results: IRR scores of profile characteristic Illegal activities were high across the three studies (ICC ≥ 0.75). Following training procedures in study 2 and 3, reliability estimates remained low to moderate (ICC < 0.75) for the profile characteristics Support of relatives, Aggression recent and lifetime, substance use and insight recent. IRR scores of the other eight profile characteristics varied from low, moderate to high across studies. Conclusion: IRR scores of profile characteristics were highly variable, and mostly inadequate in all three studies. Consequently, further research should focus on specification of severity scores of profile characteristics, optimizing scoring methods and re‐evaluation of IRR. [ABSTRACT FROM AUTHOR]

Background: Antidepressant trials are criticized due to potential methodological flaws. Root causes of failing methodology can be found in insufficient inter-rater reliability (IRR) and training practices, leading to higher placebo response and reduced study-power. However, it is unknown to what extent reliability estimates or training procedures are currently included in antidepressant reports. Therefore, we aimed to determine the proportion of publications concerning double-blind randomized controlled antidepressant trials that report on IRR coefficients and training procedures.Methods: We extracted all double-blind randomized clinical trials (RCTs) from the meta-analysis of Cipriani et al. (2018) concerning the period from 2000 until January 2016. Further, we conducted a Medline-search for double-blind RCTs from January 2016 until January 2020 for additional reports. We identified IRR coefficients and training procedures in these publications.Results: In total we identified 179 double-blind RCTs. Only 4.5% reported an IRR coefficient whereas 27.9% reported training procedures.Limitations: We did not contact individual authors for additional information regarding implementation of training procedures or inter-rater reliability assessment.Conclusions: There is a substantial lack of reporting IRR coefficients and training procedures in RCTs with antidepressant medication. Considering the large implications of insufficient reliability, we urge researchers to conduct and report training procedures and reliability estimations. [ABSTRACT FROM AUTHOR]

The human olfactory bulb and peduncle contain several more or less separated cell groups that are usually regarded to be part of the retrobulbar anterior olfactory nucleus (AON). The assumption that these cell groups are to be considered as the rostral extension of the AON in the rostral hemisphere goes back to the description of one single case by Crosby and Humphrey (1941). To improve our understanding of the anatomy of the human bulbar and peduncular AON, we investigated the morphology, size and shape of these parts of this nucleus in postmortem tissue of aged individuals. Six olfactory bulbs and peduncles including the substantia perforata anterior (SPA) were obtained from donor brains and 40μm horizontal serial sections were cut and stained with Nissl substance. The medium to large sized neurons of these parts of the AON were intensely stained and had an average diameter of 16μm. Three dimensional reconstruction demonstrated that in all but one of the cases the bulbar and peduncular AON consisted on a discontinuous chain of cell groups connected by cell poor to cell free bridges of neuropile. The number of cell groups and the connecting bridges differ in every individual. We arrived at the conclusion that the bulbar and peduncular parts of the human AON should be regarded a human specialization rather than just being rostral extensions of the retrobulbar AON area. This is in line with previously published neurochemical properties and the selective early, preclinical degener-ation of these cell clusters in neurodegenerative diseases. [ABSTRACT FROM AUTHOR]